127 related articles for article (PubMed ID: 6547874)
1. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients.
Goodnough LT; Saito H; Manni A; Jones PK; Pearson OH
Cancer; 1984 Oct; 54(7):1264-8. PubMed ID: 6547874
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of metastatic breast cancer].
Yahalom J; Biran S; Sulkes A
Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
[No Abstract] [Full Text] [Related]
3. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Rivkin SE; Glucksberg H; Foulkes M
Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
[No Abstract] [Full Text] [Related]
4. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
5. The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer.
Nolan L; Darby A; Boleti K; Simmonds P
Breast; 2011 Apr; 20(2):151-4. PubMed ID: 20970333
[TBL] [Abstract][Full Text] [Related]
6. Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancer.
Price LA; Hill BT
Cancer Treat Rev; 1990 Sep; 17(2-3):191-6. PubMed ID: 2272033
[No Abstract] [Full Text] [Related]
7. An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer.
Segaloff A; Hankey BF; Carter AC; Escher GC; Ansfield FJ; Talley RW
Breast Cancer Res Treat; 1985; 5(3):311-9. PubMed ID: 3896353
[TBL] [Abstract][Full Text] [Related]
8. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
10. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
Hirshaut Y; Kesselheim H
Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698
[TBL] [Abstract][Full Text] [Related]
11. Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast.
Huntington MO
Cancer; 1985 Aug; 56(3):472-4. PubMed ID: 3839160
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
[TBL] [Abstract][Full Text] [Related]
13. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.
Levine MN; Gent M; Hirsh J; Arnold A; Goodyear MD; Hryniuk W; De Pauw S
N Engl J Med; 1988 Feb; 318(7):404-7. PubMed ID: 3340118
[TBL] [Abstract][Full Text] [Related]
14. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.
Tormey DC; Weinberg VE; Holland JF; Weiss RB; Glidewell OJ; Perloff M; Falkson G; Falkson HC; Henry PH; Leone LA
J Clin Oncol; 1983 Feb; 1(2):138-45. PubMed ID: 6366133
[TBL] [Abstract][Full Text] [Related]
16. Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
Budd GT; Green S; O'Bryan RM; Martino S; Abeloff MD; Rinehart JJ; Hahn R; Harris J; Tormey D; O'Sullivan J
J Clin Oncol; 1995 Apr; 13(4):831-9. PubMed ID: 7707108
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Muss HB; White DR; Cooper MR; Richards F; Spurr CL
Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
20. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
Pritchard KI; Paterson AH; Paul NA; Zee B; Fine S; Pater J
J Clin Oncol; 1996 Oct; 14(10):2731-7. PubMed ID: 8874334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]